Evaluation of the thrombin generation potential of a recombinant factor IX Fc fusion protein (rFIXFc) in a phase 3 multi-national clinical trial

被引：0
|
作者：
Yang Buyue [1 ]
Jiang, Haiyan [1 ]
Luk, Alvin [1 ]
Pierce, Glenn F. [1 ]
Sommer, Jurg M. [1 ]
机构：
[1] Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [21] Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animals
    Dumont, Jennifer A.
    Loveday, Kenneth S.
    Light, David R.
    Pierce, Glenn F.
    Jiang, Haiyan
    THROMBOSIS RESEARCH, 2015, 136 (02) : 371 - 378
  • [22] Clinical trial for long-lasting recombinant factor IX-FC (rFIXFc) in subjects with haemophilia B (B-LONG)
    Luk, A.
    Jiang, H.
    Gust, S.
    Defeo-Fraulini, T.
    Roberts, A.
    Pierce, G.
    HAEMOPHILIA, 2011, 17 (02) : 355 - 355
  • [23] Population pharmacokinetic analysis of a long-acting recombinant factor IX-FC fusion protein (RFIXFC) in patients with severe haemophilia B
    Diao, L.
    Li, S.
    Nestorov, I.
    Jiang, H.
    HAEMOPHILIA, 2013, 19 : 33 - 33
  • [24] A prospective post-authorization safety surveillance study in Japanese hemophilia B patients with recombinant factor IX Fc fusion protein (rFIXFc)
    Hanabusa, Hideji
    Higasa, Satoshi
    Taki, Masashi
    Kobayashi, Masao
    Hashizume, Akio
    Makioka, Haruki
    Shiraishi, Mutsumi
    Hirakata, Toshiyuki
    HAEMOPHILIA, 2016, 22 : 52 - 52
  • [25] Clinical Evaluation of a Novel, Long-Lasting Recombinant Fc Fusion Replacement Factor (Rfixfc) in Patients with Severe Hemophilia B
    Shapiro, Amy
    Pasi, John
    Gust, Stephen
    DeFeo-Fraulini, Tia
    Thomas, Gareth
    Li, Lian
    Dabora, Sandra
    Krassova, Snejana
    Luk, Alvin
    Pierce, Glenn
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S174 - S174
  • [26] Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B
    Pasi, K. John
    Fischer, Kathelijn
    Ragni, Margaret
    Nolan, Beatrice
    Perry, David J.
    Kulkarni, Roshni
    Ozelo, Margareth
    Mahlangu, Johnny
    Shapiro, Amy D.
    Baker, Ross I.
    Bennett, Carolyn M.
    Barnes, Christopher
    Oldenburg, Johannes
    Matsushita, Tadashi
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    Mei, Baisong
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (03) : 508 - 518
  • [27] Clinical evaluation of a novel, long-lasting recombinant Fc fusion replacement factor (rFIXFc) in patients with severe haemophilia B
    Shapiro, A.
    Pasi, J.
    Gust, S.
    Defeofraulini, T.
    Thomas, G.
    Li, L.
    Dabora, S.
    Krassova, S.
    Luk, A.
    Pierce, G.
    HAEMOPHILIA, 2012, 18 : 40 - 40
  • [28] Post hoc analysis to evaluate the effect of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in adults and adolescents with target joints and hemophilia B
    Kulkarni, Roshni
    Pasi, K. John
    Liesner, Raina
    Hanabusa, Hideji
    Feng, Jingyuan
    Ferrante, Francesca
    Mei, Baisong
    Jain, Nisha
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [29] Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: A Interim Analysis Of The Kids B-LONG Study
    Fischer, Kathelijn
    Kulkarni, Roshni
    Bradbury, Myles
    Ragni, Margaret V.
    Rangarajan, Savita
    Dong, Yingwen
    Li, Shuanglian
    Jiang, Haiyan
    Nugent, Karen
    Pierce, Glenn F.
    Allen, Geoffrey
    BLOOD, 2013, 122 (21)
  • [30] Clinical Outcomes in Children with Haemophilia B Treated Long Term with Recombinant Factor IX FC Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-YOND Extension Study
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Bennett, C. M.
    Perry, D. J.
    Barnes, C.
    Yuan, H.
    Ramirez-Santiago, A.
    Pierce, G. F.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 47 - 48
12345